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ABsTRACT
Macroautophagy (herein autophagy) is a cellular process, requiring ATG5, by which 
cells deliver double membrane‑bound packets containing cytoplasm or cytoplasmic 
organelles to the lysosome. This process has been reported in some cases to be antiviral, 
while in other cases it has been reported to be required for efficient viral replication or 
release. A role for autophagy in RNA virus replication has been an attractive hypothesis 
because of the association of RNA virus replication with complex membrane rearrange‑
ments in the cytoplasm that can generate opposed double membranes. In this study 
we demonstrate that ATG5 is not required for murine hepatitis virus (MHV) replication 
in either bone marrow derived macrophages (BMMj) lacking ATG5 by virtue of Cre‑
recombinase mediated gene deletion or primary low passage murine ATG5‑/‑ embryonic 
fibroblasts (pMEFs). We conclude that neither ATG5 nor an intact autophagic pathway 
are required for MHV replication or release.
INTRoDuCTIoN
Autophagy is an evolutionarily conserved cellular process in which a series of cyto‑
plasmic proteins generate isolation membranes that envelop cytoplasm and cytoplasmic 
organelles, resulting in double‑membrane bound packets of cytoplasmic constituents about 
0.5 to 1.5 mm in diameter.12,13,20,21,32,42 This enveloped packet of cytoplasm is delivered 
to the lysosome for degradation via fusion of the outer membrane of the autophagosome 
with the lysosomal membrane. Autophagy plays an important role in multiple biological 
processes including development,12,19,20,26,31 tumor suppression,4,14,18,30,43 prevention of 
neurodegeneration,7,10 survival during starvation or growth factor withdrawal,11,17,20 and 
T cell homeostasis.29
Autophagy requires the concerted action of a series of proteins that together generate 
the curved membranes responsible for envelopment of cytoplasm and delivery of captured 
cytoplasmic constituents to the lysosome.21,42 Envelopment of cytoplasm during 
autophagy requires two ATG5‑dependent protein conjugation systems.21,22,24 The first 
of these generates ATG5‑ATG12 conjugates which become associated with the elongating 
isolation membrane during autophagy.21 This system is highly efficient; the majority of 
ATG5 in cells is found conjugated to ATG12. A second conjugation system modifies the 
free C‑terminal glycine of the autophagy protein ATG8/LC3 (termed LC3‑I) with phos‑
phatidylethanolamine generating LC3‑II which associates with autophagosomes. LC3‑I 
and LC3‑II can be distinguished by mobility in electrophoretic gels. The conversion of 
LC3‑I to LC3‑II depends on ATG5‑ATG12 conjugation.22 Homozygous deletion of 
ATG5 results in neonatal lethality in mice.11 Therefore mice in which the third exon of 
ATG5 is flanked by LoxP sites have been used in combination with cell type‑specific expres‑
sion of the Cre recombinase to study autophagy in adult animals [ATG5flox/flox,7,11].
Two attributes of autophagy have drawn the attention of virologists. First, the potential 
ability to deliver cytoplasmic virions or replication factories to the lysosome suggests that 
autophagy could serve as a mechanism for combating cytoplasmic viral replication. Data 
consistent with such an antiviral role for autophagy and autophagy genes was originally 
obtained for Sindbis virus15 and subsequently for herpes simplex virus25,36,37 and tobacco 
mosaic virus.16 The observation that two different herpesvirus proteins, a viral Bcl‑2 
family member27 and the herpes simplex virulence factor ICP34.525,36 inhibit autophagy 
indicates that viruses have evolved potent ways to antagonize the antiviral effects of 







































ATG5 is Not Required for Coronavirus Replication
autophagy. The existence of such autophagy evasion proteins 
supports the concept that autophagy is an important antiviral innate 
immune pathway.
However, as opposed to the idea that autophagy is antiviral, 
the similarity in structure between the curved double membrane 
of autophagosomes and membrane structures observed by electron 
microscopy in association with RNA or poxvirus replication has 
suggested that the autophagic pathway, or at least specific autophagy 
genes, might be subverted to foster viral replication. This concept is 
supported by studies of coronavirus replication in embryonic stem 
cells28 and poliovirus replication in MCF7 and Hela cells.9 In each 
case, initial support for a role for autophagy in viral replication came 
from studies colocalizing viral proteins with autophagy proteins. In 
embryonic stem cells lacking ATG5, replication of the coronavirus 
murine hepatitis virus (MHV strain A59) was decreased more than 
1000‑fold compared to cells expressing ATG5.28 In contrast to these 
observations, replication of vaccinia virus, a DNA poxvirus whose 
replication also involves a series of complex cytoplasmic membrane 
rearrangements, does not require ATG5.44
We sought to further evaluate the possible role of ATG5 and an 
intact autophagy pathway in coronavirus replication. It is well recog‑
nized that primary cells and continuous or transformed cell lines can 
differ in their permissiveness for viral replication. Moreover, viruses 
exhibit tropism for specific cells in vivo,38 making it important to 
evaluate the role of host proteins in relevant primary cell types when 
experimentally feasible. Since the autophagic machinery may be 
altered in transformed cell lines, and since embryonic stem cells are 
not directly involved in viral pathogenesis, we determined whether 
ATG5 and an intact autophagic pathway is required for coronavirus 
replication in both primary BMMj and primary low passage MEFs. 
In contrast to studies in embryonic stem cells using the same strain of 
virus,28 ATG5 was not required for MHV‑A59 replication in either 
cell type. We conclude that, similar to studies of vaccinia virus repli‑
cation,44 neither an intact autophagy pathway nor the autophagy 
gene ATG5 is required for coronavirus replication.
MATERIALs AND METHoDs
Mice. ATG5‑/‑ and ATG5flox/flox mice have been described.7,11 
Mice expressing the Cre recombinase from within the lysozyme M 
locus (Lyz‑Cre mice) were purchased from the Jackson Laboratory 
(Strain # 004781). Mice were genotyped as described,7 with the 
ATG5 gene detected with the primers exon3‑1, short2 and check2 
run using PCR [94˚C (4 min); 30 cycles of 94˚C (30 sec), 60˚C 
(30 sec), 72˚C (1 min); 72˚C (5 min)]. The Cre gene was detected 
with primers cre1 and cre2 using PCR [94˚C (4 min); 25 cycles of 
94˚C (30 sec), 60˚C (30 sec), 72˚C (1 min); 72˚C (5 min)].
Macrophages and viral infection of macrophages. BMMj 
cultures were maintained in low‑endotoxin DMEM with 4.5 g/ml 
glucose Mediatech, Herndon VA), 100 U/ml penicillin/100 mg/
ml streptomycin (Mediatech, Herndon VA), and 10% HEPES 
(Mediatech, Herndon VA) at 37˚C with 5% CO2 unless other‑
wise noted. BMMj were isolated from the femurs and tibias of 
Atg5flox/flox‑Lyz‑Cre and Atg5flox/flox mice. Bone marrow was flushed 
out with BM20 medium containing low‑endotoxin DMEM with 
4.5 g/ml glucose, 2 mM L‑glutamine (Washington University 
School of Medicine tissue culture support center, St. Louis MO), 
1 mM sodium pyruvate (Mediatech, Herndon VA), 10% defined 
low endotoxin FCS (Hyclone, Logan UT), 5% defined equine serum 
(Hyclone, Logan UT), and 20% L929 cell conditioned medium 
[LCM,8]. Cells were plated in BM20 at 3 x 105 cells/ml in 8 mls in 
non‑tissue culture treated dishes (Fisher Scientific, Fair Lawn NJ). 
After four days an additional 8 mls of BM20 was added. Cells were 
harvested by scraping on day 7 of culture, and replated with BM10 
(same as BM20 except containing 10% LCM) for experiments. For 
all experiments murine coronavirus strain MHV‑A59 stocks were 
generated and titered by plaque assay using 17 Cl 1 cells.6,34 For 
detection of viral replication in BMMj, 1.5 x 105 cells were plated 
in 1.0 ml of BM10 in 12‑well tissue culture treated plates (Corning, 
Corning NY) for two days. BM10 medium was then removed and 
replaced with either BM10 plus 1% MEM nonessential amino acids 
(Mediatech, Herndon VA) and 2% MEM amino acids (Invitrogen, 
Grand Island NY) [“non‑starved” condition] or Earle’s balanced salt 
solution (EBSS; Sigma, St. Louis MO) [“starved” condition] for 
2 hours. Medium was then removed and replaced with 0.2 mls of 
starved or non‑starved medium containing 7.5 x 104 plaque forming 
units (PFU) of MHV‑A59 (moi = 0.5). After incubating for 1 hr at 
37˚C, monolayers were washed three times with BM10 to remove 
unbound virus, and 1.0 ml of BM10 was added. A plate was frozen 
immediately for later titration as the t = 0 time point. To assess 
released virus, 0.5 ml of supernatant from each well was removed and 
stored at ‑80˚C for viral titration. To assess total virus production, 
a plate was frozen for later titration after removal of 0.5 ml super‑
natant for “released” virus. Samples were freeze‑thawed three times 
and titrated by plaque assay on 17 C1 1 cells.
Fibroblasts and viral infection of fibroblasts. All fibroblast 
cultures were maintained in 100 U/ml penicillin, 100 mg/ml strepto‑
mycin, and 10 mM HEPES at 37˚C with 5% CO2 unless otherwise 
noted. Primary ATG5+/+ and ATG5‑/‑ mouse embryonic fibro‑
blasts (pMEFs) were prepared from 13.5‑day embryos by carefully 
dissecting the embryo from associated uterine and placental tissue 
and mincing prior to culture. pMEFs were maintained in Dulbecco’s 
modified Eagle’s medium supplemented with 10% characterized 
FCS (Hyclone, Logan VA), 2 mM L‑glutamine, 1% MEM non‑ 
essential amino acids, 2% MEM amino acids. pMEFs were harvested 
by trypsinization and replated for experiments. For detection of 
MHV‑A59 replication in pMEFs, 5 x 105 cells in 2 ml of non‑starved 
DMEM10 medium (DMEM10 with 1% MEM nonessential amino 
acids, 2% MEM amino acids) were plated per well in 6 well plates 
(Corning, Corning NY) and cultured overnight. After washing three 
times with 4°C EBSS, cells were incubated in 2 ml non‑starved 
DM M‑10 medium or “starved” medium (EBSS) for 2 hr. Medium 
was then removed and replaced with 0.5 ml of either starved or 
unstarved medium containing 2.5 x 105 PFU of MHV‑A59 (moi = 
0.5) and incubated at 37°C for 1 hr. Infected cells were washed three 
times with 2 ml of DMEM10 per well to remove unbound virus 
and then incubated in 2 ml of non‑starved DMEM10 for the indi‑
cated time prior to freezing for later titration by plaque assay as 
described above.
Immunoblots. Cells pellets were lysed on ice in lysis buffer 
[50 mM Tris‑HCl (Fisher Scientific, Fair Lawn NJ), pH 7.4, 150 mM 
NaCl (Fisher Scientific, Fair Lawn NJ), 1% Triton X‑100 (Sigma, 
St. Louis MO), 1mM EDTA (Fisher Scientific, Fair lawn NJ)] for 
30 min in presence of 1 mM PMSF (Sigma, St. Louis MO) and 4% 
protein inhibitor cocktail‑III (Roche Applied Science, Indianapolis 
IN) and subjected to western blotting using antibodies specific 
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for ATG5,22 LC3 (Novus Biologicals, Littleton CO), and b‑actin 
(Sigma‑Aldrich, St. Louis MO). Immunoblots were developed with 
HRP‑conjugated secondary antibodies (Jackson Immunoreseach, 
West Grove PA) and visualized by chemiluminescence (Amersham 
Biosciences, Pittsburgh PA).
Statistical analysis. All data were analyzed with Prism software 
(GraphPad, San Diego, CA) using two‑tailed unpaired t test.
REsuLTs AND DIsCussIoN
Mj are involved in the pathogenesis of coronavirus 
infection. Mj are infected in the lungs of patients with 
coronavirus‑induced SARS,23,41 the virulence of feline 
coronavirus is associated with macrophage tropism,33 
macrophages are amongst the first cells infected in mice 
inoculated with the coronavirus MHV‑A59,39,40 and 
BMMj are permissive for MHV‑A59 replication.35 We 
therefore selected macrophages as a relevant primary cell 
type in which to test the hypothesis that ATG5 and an 
intact autophagy pathway is required for coronavirus 
replication.
To generate Mj lacking ATG5 we bred ATG5flox/flox 
mice7 to mice in which the Cre recombinase is expressed 
from the endogenous lysozyme M locus (Lyz‑Cre).2 
Lysozyme M expression is restricted to myelomono‑
cytic cells, specifically Mj and granulocytes.1,3,5 We 
then cultured BMMj from ATG5flox/flox‑Lyz‑Cre and 
ATG5flox/flox mice (Fig. 1A) and analyzed expression 
of ATG5‑ATG12 conjugates and the conversion of 
LC3‑I to LC3‑II in these cells (Fig. 1B). We observed 
no differences in the generation of BMMj between 
ATG5flox/flox‑Lyz‑Cre and ATG5flox/flox bone marrow (data 
not shown). ATG5flox/flox‑Lyz‑Cre BMMj expressed significantly 
lower levels of ATG5‑ATG12 conjugates than ATG5flox/flox BMMj 
(Fig. 1B). In addition, we observed a significant decrease in the 
amount of LC3‑II in ATG5flox/flox‑Lyz‑Cre BMMj compared to 
ATG5flox/flox BMMj (Fig. 1B) under both starved and unstarved 
conditions. These data indicated that expression of the Cre recom‑
binase from the lysozyme M locus effectively deletes the ATG5 gene 
in cultured BMMj, and that, as expected, ATG5 is required for 
efficient conversion of LC3‑I to LC3‑II in macrophages.
We next examined the replication of MHV‑A59 in ATG5flox/
flox‑Lyz‑Cre BMMj compared to ATG5flox/flox BMMj (Fig. 2). 
BMMj were infected and viral titers determined at various times 
over a period of 48 hours. We compared the amount of virus released 
into the supernatant compared to the total amount of infectious virus 
produced because of the proposed role of autophagy in virus release.9 
In addition, we compared BMMj cultured under starved and 
unstarved conditions. MHV‑A59 replicated to the same levels regard‑
less of the presence or absence of ATG5 or the culture conditions. 
There was no effect of ATG5 on the amount of released MHV‑A59. 
This demonstrated that neither ATG5 nor an intact autophagic 
pathway is required for MHV‑A59 replication in, or release from, 
BMMj. Further, the induction of autophagy by starvation did not 
alter viral replication or release.
These results are in contrast to studies in embryonic stem cells.28 
It could be argued that this difference between embryonic stem cells 
and BMMj was due the presence of ATG5 or autophagic conver‑
sion of LC3‑I to LC3‑II at levels below those detectable by western 
blot. To address this possibility using cells that lack ATG5 due to a 
null mutation in the ATG5 gene rather than Cre‑recombinase medi‑
ated deletion of the ATG5 gene, we isolated ATG5‑/‑, ATG5+/‑ and 
ATG5+/+ murine embryonic fibroblasts. These cells were used as low 
passage (less than 5 passages, termed primary MEFs or pMEFs) cells 
in order to prevent changes in cell physiology associated with passage 
crisis and selection of continuous MEFs.
Figure 1. Bone marrow macrophages from ATG5flox/flox‑Lyz‑Cre mice are ATG5 deficient 
and convert LC3‑I to LC3‑II inefficiently. (A) PCR products from genotyping BMMj cultured 
from mice of the following genotypes: ATG5flox/flox‑Lyz‑Cre (left lane), ATG5flox/wild 
type (middle lane) and ATG5flox/flox (right lane). The predicted sizes of the bands gener‑
ated by PCR are: ATG5flox: 651bp; ATG5: 351 bp; Cre: 250bp. (B) Western blot with 
antibodies detecting ATG5‑12 conjugates (upper panel) and LC3‑I/II proteins (lower 
panel) from either ATG5flox/flox‑Lyz‑Cre (lanes 1 and 2) or ATG5flox/flox (lanes 3 and 4) 
BMMj under starved (lanes 2 and 4) or non‑starved (lanes 1 and 3) conditions. These 
data are representative of at least two experiments.
Figure 2. MHV‑A59 replication in bone marrow macrophages does not 
require ATG5. MHV‑A59 titers produced by BMMj derived from either 
ATG5flox/flox‑Lyz‑Cre (empty square, dotted line) or ATG5flox/flox (filled square, 
solid line) mice. All experiments were done at moi = 0.5. Titers are shown 
separately for starved (left panels) and non‑starved (right panels) conditions. 
Titers of released virus are shown in the upper two panels; total virus titers 
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We confirmed the genotype of these cells by PCR (Fig. 3A). 
Western blot revealed the expected lack of ATG5‑ATG12 conjugates 
in ATG5‑/‑ MEFs (Fig. 3B). As expected, ATG5‑/‑ MEFs contained 
undetectable LC3‑II even under starvation conditions (Fig. 3B). 
Together these data show that pMEFs had the predicted ATG5 defi‑
ciency and consequent lack of normal autophagy.
Next we performed growth experiments in starved and unstarved 
pMEFs. Cells were infected with MHV‑A59 and virus titers deter‑
mined over four days in culture (Fig. 4A and B). Consistent with 
results obtained in ATG5flox/flox‑Lyz‑Cre BMMj (Fig. 2), ATG5 
was not required for replication of MHV‑A59 in pMEFs. We also 
assessed the growth of MHV‑A59 during the first 24 hours of infec‑
tion (Fig. 4C). There was no role for ATG5 or an intact autophagic 
pathway in MHV‑A59 replication at these earlier time points. Similar 
experiments were performed in Saint Louis, Missouri and Nashville, 
Tennessee, confirming that these data are representative across 
institutions and that they are independent of subtle differences in 
experimental techniques between laboratories.
These experiments indicate that, as observed for vaccinia virus,44 
ATG5 is not required for coronavirus replication. To determine if 
there was an alternative pattern of virus infection‑induced membrane 
modifications in the absence of ATG5, we used electron microscopy 
to compare the ultrastructure of MHV infected ATG5‑/‑ and ATG5+/+ 
pMEFs 24 hours after infection at an MOI of 5 under either starved 
or unstarved conditions. Pleiomorphic membrane changes were 
noted in infected cells, including expanded ER, multilamellar 
membranes, and vesicles containing large numbers of virus particles 
(data not shown). No differences in the morphology of intracel‑
lular membranes were observed in ATG5‑/‑ compared to ATG5+/+ 
cells. Similar data were obtained at 36 hours after infection in an 
independent experiment. The results indicate that there are multiple 
ATG5‑independent membrane modifications associated with MHV 
infection of pMEFs. Membrane rearrangements that are necessary 
for coronavirus replication do not require the participation of either 
ATG5 or the conversion of LC3‑I to LC3‑II in primary low passage 
pMEFs and BMMMj. Of note, we have confirmed the initial obser‑
vation28 that SARS replicase proteins and LC3 distribution overlaps 
in punctate cytoplasmic foci in infected Vero Cells (data not shown). 
The physiologic meaning of such colocalization is uncertain, but the 
results reported here showing that an intact autophagic pathway is 
not required for coronavirus replication indicates that colocalization 
between viral proteins and autophagy proteins in continuous cell 
lines should not be used as a sole indicator that autophagy is involved 
in viral replication. While ATG5 and an intact autophagic pathway 
are not required for coronavirus replication in vitro, it remains 
possible that other proteins of the autophagy pathway may play a role 
in coronavirus replication or pathogenesis.
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